APA Citation

Monteiro, P., Aguiar, C., Matos, P., Silva-Nunes, J., Birne, R., Branco, P., . . . Polónia, J. (2019). Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in patients with type 2 diabetes and established cardiovascular disease.

Chicago Style Citation

Monteiro, P., C. Aguiar, P. Matos, J. Silva-Nunes, R. Birne, P. Branco, J. Calado, M. Melo, and J. Polónia. Effect of Empagliflozin Beyond Glycemic Control: Cardiovascular Benefit in Patients With Type 2 Diabetes and Established Cardiovascular Disease. 2019.

MLA Citation

Monteiro, P., et al. Effect of Empagliflozin Beyond Glycemic Control: Cardiovascular Benefit in Patients With Type 2 Diabetes and Established Cardiovascular Disease. 2019.

Note: citation formatting may not correspond 100% to that defined by the respective standard, to manage citations it is recommended to use the software Zotero , which allows the automatic upload of Oasisbr references.